The Pfizer Documents - July 2022 Update

Creation Time	Sept. 19, 2025, 6:12 a.m.
Last Access Time	Sept. 19, 2025, 6:12 a.m.
File Size	11.7 GB
Keywords	Documents Pfizer - Update 2022 The July
Total Requests	1
Total Files	725
Magnet Link	Please wait ...
	Download (Magnet Link) Play (Watch Online)

pd-production-070122/FDA-CBER-2021-5683-0225598 to -0282129_125742_S1_M5_c4591001-A-Supp-D-adfacevd.xpt 3.9 GB
pd-production-050222/FDA-CBER-2021-5683-0066701 to -0123167_125742_S1_M5_c4591001-A-D-adfacevd.xpt 3.9 GB
pd-production-060122/FDA-CBER-2021-5683-0142307 to -0149081_125742_S1_M5_c4591001-A-Supp-D-adcevd.xpt 426.0 MB
pd-production-050222/FDA-CBER-2021-5683-0059000 to -0065773_125742_S1_M5_c4591001-A-D-adcevd.xpt 394.4 MB
pd-production-060122/FDA-CBER-2021-5683-0149082 to -0158559_125742_S1_M5_c4591001-S-D-ce.xpt 368.1 MB
pd-production-060122/FDA-CBER-2021-5683-0196049 to -0205317_125742_S1_M5_c4591001-S-Supp-D-ce.xpt 361.4 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events.pdf 183.4 MB
pd-production-050222/FDA-CBER-2021-5683-0123168 to -0126026_125742_S1_M5_c4591001-A-D-adva.xpt 162.9 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-lab-measurements.pdf 91.1 MB
pd-production-070122/FDA-CBER-2021-5683-0286267 to -0296903_125742_S1_M5_c4591001-S-Supp-D-suppce.xpt 83.2 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-randomization-sensitive.pdf 64.9 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization-sensitive.pdf 59.4 MB
pd-production-070122/FDA-CBER-2021-5683-0296904 to -0307543_125742_S1_M5_c4591001-S-D-suppce.xpt 53.6 MB
pd-production-070122/FDA-CBER-2021-5683-0282366 to -0285643_125742_S1_M5_c4591001-S-D-mb.xpt 48.2 MB
pd-production-060122/FDA-CBER-2021-5683-0159487 to -0162689_125742_S1_M5_c4591001-S-D-ec.xpt 46.6 MB
pd-production-070122/FDA-CBER-2021-5683-0225100 to -0225597_125742_S1_M5_c4591001-A-D-adcm.xpt 46.4 MB
pd-production-060122/FDA-CBER-2021-5683-0162690 to -0165892_125742_S1_M5_c4591001-S-D-ex.xpt 44.7 MB
pd-production-060122/FDA-CBER-2021-5683-0205318 to -0208520_125742_S1_M5_c4591001-S-Supp-D-ex.xpt 44.7 MB
pd-production-050222/FDA-CBER-2021-5683-0065774 to -0066700_125742_S1_M5_c4591001-A-D-addv.xpt 43.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-report-body.pdf 41.6 MB
pd-production-060122/FDA-CBER-2021-5683-0208521 to -0216666_125742_S1_M5_c4591001-S-Supp-D-suppvs.xpt 39.2 MB
pd-production-060122/FDA-CBER-2021-5683-0187906 to -0196048_125742_S1_M5_c4591001-S-D-suppvs.xpt 39.1 MB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-protocol.pdf 36.9 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-adverse-events.pdf 31.7 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-protocol.pdf 31.3 MB
pd-production-060122/FDA-CBER-2021-5683-0165893 to -0168682_125742_S1_M5_c4591001-S-D-is.xpt 29.4 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-demographics.pdf 27.8 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-demographics.pdf 27.7 MB
pd-production-060122/FDA-CBER-2021-5683-0174607 to -0178318_125742_S1_M5_c4591001-S-D-suppdv.xpt 23.4 MB
pd-production-060122/FDA-CBER-2021-5683-0182981 to -0187905_125742_S1_M5_c4591001-S-D-suppmh.xpt 21.6 MB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-narrative-sensitive.pdf 18.9 MB
pd-production-030122/125742_S1_M5_c4591001-T-S-updated-reacto-tlf.pdf 17.4 MB
pd-production-060122/FDA-CBER-2021-5683-0171524 to -0174606_125742_S1_M5_c4591001-S-D-suppds.xpt 16.9 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients-sensitive.pdf 15.7 MB
pd-production-070122/125742_S2_M5_5354_wi235284-protocol.pdf 15.5 MB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-B.pdf 13.8 MB
pd-production-060122/FDA-CBER-2021-5683-0169082 to -0171523_125742_S1_M5_c4591001-S-D-suppdm.xpt 13.7 MB
pd-production-013122/CRFs-for-site-1128.pdf 13.6 MB
pd-production-123021/CRFs-for-site-1081.pdf 13.2 MB
pd-production-030122/125742_S1_M5_5351_c4591001-interim-mth6-oversight-committees.pdf 13.0 MB
pd-production-120121/Pages-42-289-Section-5.2-listing-clinical-sites-cvs_Part-A.pdf 12.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements.pdf 12.0 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sponsor-signature.pdf 11.9 MB
pd-production-060122/FDA-CBER-2021-5683-0158560 to -0159486_125742_S1_M5_c4591001-S-D-dv.xpt 11.4 MB
pd-production-011822/CRFs-for-site-1096.pdf 11.3 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-publications.pdf 11.2 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-interlab-standard.pdf 10.9 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol.pdf 10.5 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-publications.pdf 9.8 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sample-crf.pdf 9.1 MB
pd-production-070122/FDA-CBER-2021-5683-0285652 to -0286071_125742_S1_M5_c4591001-S-D-pe.xpt 8.9 MB
pd-production-060122/FDA-CBER-2021-5683-0178319 to -0180190_125742_S1_M5_c4591001-S-D-suppho.xpt 8.2 MB
pd-production-111721/5.2-listing-of-clinical-sites-and-cvs-pages-1-41.pdf 8.0 MB
pd-production-060122/FDA-CBER-2021-5683-0180191 to -0182980_125742_S1_M5_c4591001-S-D-suppis.xpt 8.0 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-iec-irb-consent-form.pdf 7.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-compliance.pdf 7.4 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-adverse-events.pdf 7.1 MB
pd-production-121321/STN-125742_0_0-Section-2.7.4-summary-clin-safety.pdf 6.5 MB
pd-production-121321/CRFs-for-site-1055.pdf 6.4 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-investigators.pdf 6.3 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-lab-measurements-sensitive.pdf 5.4 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sample-crf.pdf 5.4 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-sap.pdf 5.4 MB
pd-production-050222/125742_S1_M5_5351_c4591001-interim-mth6-sample-crf.pdf 5.4 MB
pd-production-030122/125742_S1_M4_4223_R-20-0072.pdf 5.2 MB
pd-production-030122/125742_S1_M1_3674.pdf 5.1 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-lab-measurements-sensitive.pdf 4.8 MB
pd-production-060122/STN 125742-0-0 Section 2.5 Clinical Overview reissue.pdf 4.7 MB
pd-production-121321/STN-125742_0_0-Section-2.5-Clinical-Overview.pdf 4.2 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-discontinued-patients.pdf 4.2 MB
pd-production-070122/FDA-CBER-2021-5683-0282130 to -0282328_125742_S1_M5_c4591001-S-D-cm.xpt 4.0 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061040.pdf 3.8 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-synopsis.pdf 3.7 MB
pd-production-030122/125742_S1_M1_financial-cert-3454.pdf 3.4 MB
pd-production-070122/125742_S1_M5_5351_c4591001-fa-interim-sap.pdf 3.2 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031113.pdf 3.2 MB
pd-production-121321/STN-125742_0_0-Section-2.7.3-Summary-of-Clinical-Efficacy.pdf 3.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131786.pdf 3.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071050.pdf 3.0 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-discontinued-patients.pdf 2.9 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sap.pdf 2.9 MB
pd-production-050222/125742_S1_M5_c4591001-S-acrf.pdf 2.9 MB
pd-production-050222/125742_S1_M5_c4591001-S-Supp-acrf.pdf 2.9 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients-sensitive.pdf 2.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131176.pdf 2.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071306.pdf 2.8 MB
pd-production-060122/FDA-CBER-2021-5683-0168683 to -0169081_125742_S1_M5_c4591001-S-D-suppcm.xpt 2.7 MB
pd-production-030122/125742_S1_M1_waiver-req-designated-suffix.pdf 2.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031038.pdf 2.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031065.pdf 2.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061176.pdf 2.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011093.pdf 2.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-patient-batches.pdf 2.6 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151238.pdf 2.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031186.pdf 2.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051293.pdf 2.4 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-efficacy-response.pdf 2.4 MB
pd-production-032422/125742_S1_M1_priority-review-request.pdf 2.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131699.pdf 2.3 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-demographics.pdf 2.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131554.pdf 2.3 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-sponsor-signature.pdf 2.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131190.pdf 2.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-oversight-committees.pdf 2.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-errata.pdf 2.3 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851018.pdf 2.3 MB
pd-production-030122/125742_S1_M5_c4591001-T-S-final-reacto-tables-track.pdf 2.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131718.pdf 2.2 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011100.pdf 2.1 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061052.pdf 2.1 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061094.pdf 2.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071097.pdf 2.1 MB
pd-production-060122/125742_S1_M5_5314_shi-sop-10011.pdf 2.1 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance.pdf 2.0 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-excluded-patients.pdf 2.0 MB
.pad/2093792 2.0 MB
.pad/2092509 2.0 MB
.pad/2088512 2.0 MB
.pad/2088447 2.0 MB
.pad/2088427 2.0 MB
.pad/2088038 2.0 MB
.pad/2087828 2.0 MB
.pad/2087828 2.0 MB
.pad/2087781 2.0 MB
.pad/2087731 2.0 MB
.pad/2087729 2.0 MB
.pad/2087487 2.0 MB
.pad/2087339 2.0 MB
.pad/2087144 2.0 MB
.pad/2087023 2.0 MB
.pad/2086653 2.0 MB
.pad/2086558 2.0 MB
.pad/2085842 2.0 MB
.pad/2085796 2.0 MB
.pad/2085790 2.0 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-discontinued-patients.pdf 2.0 MB
.pad/2085324 2.0 MB
.pad/2085199 2.0 MB
.pad/2085163 2.0 MB
.pad/2084592 2.0 MB
.pad/2084417 2.0 MB
.pad/2083861 2.0 MB
.pad/2082947 2.0 MB
.pad/2082484 2.0 MB
.pad/2082135 2.0 MB
.pad/2082049 2.0 MB
.pad/2081683 2.0 MB
.pad/2081232 2.0 MB
.pad/2079719 2.0 MB
.pad/2078783 2.0 MB
.pad/2078228 2.0 MB
.pad/2077840 2.0 MB
.pad/2077226 2.0 MB
.pad/2077131 2.0 MB
.pad/2075303 2.0 MB
.pad/2075106 2.0 MB
.pad/2074342 2.0 MB
.pad/2073880 2.0 MB
.pad/2072639 2.0 MB
.pad/2072549 2.0 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-personnel-list.pdf 2.0 MB
.pad/2069393 2.0 MB
.pad/2067726 2.0 MB
.pad/2067255 2.0 MB
.pad/2064193 2.0 MB
.pad/2061533 2.0 MB
.pad/2060836 2.0 MB
.pad/2059312 2.0 MB
.pad/2055035 2.0 MB
.pad/2052874 2.0 MB
.pad/2051278 2.0 MB
pd-production-070122/125742_S2_M1_loa-dmf-031786-vials.pdf 2.0 MB
.pad/2047036 2.0 MB
pd-production-122221/Supplemental-Index-12-22-21.pdf 1.9 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851129.pdf 1.9 MB
.pad/2023871 1.9 MB
.pad/2023632 1.9 MB
.pad/2020724 1.9 MB
.pad/2020648 1.9 MB
.pad/2019948 1.9 MB
.pad/2019552 1.9 MB
.pad/2018038 1.9 MB
.pad/2015600 1.9 MB
.pad/2014149 1.9 MB
.pad/2011782 1.9 MB
.pad/2011000 1.9 MB
.pad/2008239 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071280.pdf 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071117.pdf 1.9 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051054.pdf 1.9 MB
.pad/1969297 1.9 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1128-11281009 reissue.pdf 1.9 MB
.pad/1958734 1.9 MB
.pad/1937657 1.8 MB
.pad/1935680 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071192.pdf 1.8 MB
.pad/1909495 1.8 MB
.pad/1909495 1.8 MB
.pad/1909495 1.8 MB
.pad/1909495 1.8 MB
.pad/1909495 1.8 MB
.pad/1909495 1.8 MB
.pad/1904860 1.8 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-excluded-patients.pdf 1.8 MB
.pad/1899668 1.8 MB
.pad/1897844 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121097.pdf 1.8 MB
.pad/1895252 1.8 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-errata.pdf 1.8 MB
.pad/1887761 1.8 MB
.pad/1885619 1.8 MB
.pad/1871120 1.8 MB
.pad/1868899 1.8 MB
.pad/1854768 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071276.pdf 1.8 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1081-10811194 reissue.pdf 1.8 MB
pd-production-030122/125742_S1_M2_27_synopses-indiv-studies.pdf 1.7 MB
pd-production-030122/125742_S1_M2_27_literature-references.pdf 1.7 MB
.pad/1832352 1.7 MB
pd-production-060122/125742_S1_M2_summary-biopharm.pdf 1.7 MB
.pad/1818848 1.7 MB
pd-production-070122/125742_S2_M1_right-of-reference.pdf 1.7 MB
.pad/1804176 1.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091135.pdf 1.7 MB
pd-production-111721/5.2-tabular-listing.pdf 1.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071124.pdf 1.7 MB
.pad/1794426 1.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031111.pdf 1.7 MB
.pad/1792114 1.7 MB
.pad/1790159 1.7 MB
.pad/1777447 1.7 MB
.pad/1776506 1.7 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121112.pdf 1.7 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051387.pdf 1.7 MB
.pad/1757614 1.7 MB
.pad/1746365 1.7 MB
.pad/1740343 1.7 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20242.pdf 1.7 MB
.pad/1713856 1.6 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-protocol-deviations.pdf 1.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031149.pdf 1.6 MB
.pad/1709969 1.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20215.pdf 1.6 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091128.pdf 1.6 MB
.pad/1691225 1.6 MB
pd-production-030122/125742_S1_M2_24_nonclinical-overview.pdf 1.6 MB
.pad/1676688 1.6 MB
.pad/1667904 1.6 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10075.pdf 1.6 MB
pd-production-030122/125742_S1_M1_priority-review-request.pdf 1.6 MB
.pad/1660183 1.6 MB
.pad/1659921 1.6 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061098.pdf 1.6 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1012-10121163.pdf 1.6 MB
pd-production-030122/125742_S1_M5_c4591001-A-adrg.pdf 1.5 MB
.pad/1609687 1.5 MB
.pad/1606032 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111029.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1006-10061020.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-sponsor-signature.pdf 1.5 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-randomization.pdf 1.5 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations-sensitive.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_20116.pdf 1.5 MB
.pad/1576555 1.5 MB
.pad/1551813 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031197.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071101.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091149.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-protocol-deviations.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151225.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151134.pdf 1.5 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01_10010.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051069.pdf 1.5 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071347.pdf 1.5 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051347.pdf 1.4 MB
.pad/1516912 1.4 MB
.pad/1515312 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1003-10031207.pdf 1.4 MB
.pad/1509260 1.4 MB
.pad/1505648 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131089.pdf 1.4 MB
pd-production-030122/125742_S1_M2_26_pharmkin-written-summary.pdf 1.4 MB
pd-production-050222/125742_S1_M5_c4591001-S-csdrg.pdf 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1001-10011135.pdf 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071315.pdf 1.4 MB
.pad/1484552 1.4 MB
.pad/1480471 1.4 MB
.pad/1475698 1.4 MB
.pad/1475451 1.4 MB
pd-production-030122/125742_S1_M4_4223_185350.pdf 1.4 MB
.pad/1466259 1.4 MB
.pad/1466200 1.4 MB
pd-production-050222/125742_S1_M5_bnt162-01-S-acrf.pdf 1.4 MB
.pad/1462066 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051047.pdf 1.4 MB
.pad/1457924 1.4 MB
.pad/1457347 1.4 MB
.pad/1456559 1.4 MB
.pad/1456467 1.4 MB
.pad/1456458 1.4 MB
.pad/1456310 1.4 MB
.pad/1455323 1.4 MB
.pad/1455055 1.4 MB
.pad/1454285 1.4 MB
.pad/1453899 1.4 MB
.pad/1453711 1.4 MB
.pad/1453115 1.4 MB
.pad/1452969 1.4 MB
.pad/1452648 1.4 MB
.pad/1452410 1.4 MB
.pad/1451109 1.4 MB
.pad/1450554 1.4 MB
.pad/1450394 1.4 MB
.pad/1450371 1.4 MB
.pad/1450049 1.4 MB
.pad/1447677 1.4 MB
.pad/1447505 1.4 MB
.pad/1446252 1.4 MB
.pad/1444971 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051214.pdf 1.4 MB
.pad/1442879 1.4 MB
.pad/1441672 1.4 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131084.pdf 1.4 MB
pd-production-030122/FDA-CBER-2021-5683-0023150 to -0023454_125742_S1_M5_c4591001-A-define.xml 1.4 MB
.pad/1434362 1.4 MB
.pad/1433248 1.4 MB
.pad/1432149 1.4 MB
.pad/1424982 1.4 MB
.pad/1423524 1.4 MB
pd-production-050222/125742_S1_M5_CRF_c4591001-1005-10051411.pdf 1.3 MB
.pad/1414356 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151011.pdf 1.3 MB
.pad/1410900 1.3 MB
.pad/1410832 1.3 MB
.pad/1409120 1.3 MB
pd-production-030122/125742_S1_M2_26_pharmkin-tabulated-summary.pdf 1.3 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-patient-batches.pdf 1.3 MB
.pad/1403763 1.3 MB
.pad/1403355 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131255.pdf 1.3 MB
.pad/1389509 1.3 MB
.pad/1388594 1.3 MB
.pad/1384642 1.3 MB
pd-production-030122/125742_S1_M1_cover.pdf 1.3 MB
.pad/1379241 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081603.pdf 1.3 MB
.pad/1377517 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071443.pdf 1.3 MB
.pad/1365545 1.3 MB
.pad/1362804 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131165.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071159.pdf 1.3 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-excluded-patients.pdf 1.3 MB
.pad/1347939 1.3 MB
.pad/1343098 1.3 MB
.pad/1341310 1.3 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-audit-certificates.pdf 1.3 MB
.pad/1336256 1.3 MB
.pad/1336256 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081667.pdf 1.3 MB
pd-production-060122/125742_S1_M5_5351_c4591001-fa-interim-patient-batches.pdf 1.3 MB
.pad/1325761 1.3 MB
pd-production-030122/125742_S1_M5_5351_c4591001-fa-interim-compliance-sensitive.pdf 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1009-10091123.pdf 1.3 MB
.pad/1313904 1.3 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1007-10071441.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081337.pdf 1.2 MB
.pad/1302241 1.2 MB
.pad/1299317 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151035.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151089.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131653.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151071.pdf 1.2 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851216.pdf 1.2 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-efficacy-response.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131656.pdf 1.2 MB
.pad/1276453 1.2 MB
.pad/1276006 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081056.pdf 1.2 MB
.pad/1270502 1.2 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-notes-for-reader.pdf 1.2 MB
pd-production-070122/125742_S1_M5_5351_c4591001-interim-mth6-compliance-sensitive.pdf 1.2 MB
pd-production-060122/125742_S1_M5_5351_c4591001-interim-mth6-randomization.pdf 1.2 MB
pd-production-050222/125742_S1_M5_bnt162-01-S-csdrg.pdf 1.2 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-adverse-events-sensitive.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1011-10111181.pdf 1.2 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851116.pdf 1.2 MB
.pad/1249150 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081628.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081184.pdf 1.2 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131517.pdf 1.2 MB
pd-production-040122/125742_S1_M5_5351_c4591001-interim-mth6-invest-signature.pdf 1.2 MB
.pad/1230815 1.2 MB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-protocol-deviations.pdf 1.2 MB
.pad/1215839 1.2 MB
.pad/1213179 1.2 MB
.pad/1207121 1.2 MB
.pad/1205797 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131229.pdf 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151047.pdf 1.1 MB
.pad/1201104 1.1 MB
pd-production-030122/125742_S1_M5_CRF_c4591001-1085-10851246.pdf 1.1 MB
.pad/1188889 1.1 MB
.pad/1186662 1.1 MB
.pad/1184699 1.1 MB
.pad/1171272 1.1 MB
.pad/1167910 1.1 MB
.pad/1167907 1.1 MB
.pad/1158880 1.1 MB
.pad/1147686 1.1 MB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-iec-irb.pdf 1.1 MB
.pad/1143388 1.1 MB
.pad/1132677 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131658.pdf 1.1 MB
.pad/1116549 1.1 MB
.pad/1114370 1.1 MB
.pad/1112688 1.1 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1015-10151101.pdf 1.1 MB
.pad/1089995 1.0 MB
.pad/1088003 1.0 MB
.pad/1086306 1.0 MB
pd-production-030122/125742_S1_M1_us-agent-authorization.pdf 1.0 MB
.pad/1064656 1.0 MB
pd-production-060122/125742_S1_M5_CRF_c4591001-1008-10081152.pdf 1.0 MB
.pad/1053605 1.0 MB
.pad/1051178 1.0 MB
.pad/1050398 1.0 MB
.pad/1048726 1.0 MB
pd-production-070122/125742_S2_M1_com195lkz-carton-kzoo.pdf 1023.9 KB
pd-production-070122/125742_S2_M1_loa-dmf-011321-vials.pdf 1019.1 KB
.pad/1033564 1009.3 KB
pd-production-060122/125742_S1_M5_CRF_c4591001-1013-10131386.pdf 1008.3 KB
.pad/1012417 988.7 KB
pd-production-070122/125742_S2_M1_hospira-diluent-carton.pdf 987.2 KB
pd-production-050222/FDA-CBER-2021-5683-0058829 to -0058954_125742_S1_M5_bnt162-01-S-define.xml 985.5 KB
pd-production-111721/5.3.6-postmarketing-experience.pdf 983.6 KB
.pad/995171 971.8 KB
.pad/987283 964.1 KB
pd-production-040122/reissue_5.3.6 postmarketing experience.pdf 957.6 KB
.pad/977908 955.0 KB
.pad/962962 940.4 KB
.pad/950478 928.2 KB
.pad/940784 918.7 KB
pd-production-050222/FDA-CBER-2021-5683-0058479 to -0058594_125742_S1_M5_c4591001-S-define.xml 904.2 KB
.pad/925235 903.5 KB
pd-production-050222/125742_S1_M5_bnt162-01-A-adrg.pdf 891.1 KB
.pad/911785 890.4 KB
pd-production-030122/125742_S1_M5_5351_c4591001-ad-hoc-label-tables.pdf 889.2 KB
.pad/898888 877.8 KB
.pad/896320 875.3 KB
.pad/893160 872.2 KB
.pad/892619 871.7 KB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-audit-certificates.pdf 869.2 KB
.pad/886416 865.6 KB
pd-production-070122/125742_S2_M1_comvlabkz-vial-kzoo.pdf 863.3 KB
.pad/881840 861.2 KB
pd-production-070122/125742_S2_M1_loa-dmf-10953-stopper.pdf 860.7 KB
.pad/871933 851.5 KB
pd-production-030122/125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.pdf 846.0 KB
.pad/860055 839.9 KB
.pad/859029 838.9 KB
.pad/857540 837.4 KB
.pad/854879 834.8 KB
.pad/854544 834.5 KB
.pad/852594 832.6 KB
pd-production-050222/FDA-CBER-2021-5683-0058676 to -0058794_125742_S1_M5_bnt162-01-A-define.xml 828.1 KB
.pad/845807 826.0 KB
.pad/845473 825.7 KB
.pad/841741 822.0 KB
.pad/841024 821.3 KB
.pad/840900 821.2 KB
.pad/837915 818.3 KB
.pad/832387 812.9 KB
.pad/824405 805.1 KB
.pad/823457 804.2 KB
.pad/819876 800.7 KB
.pad/817399 798.2 KB
.pad/814548 795.5 KB
.pad/814399 795.3 KB
.pad/812613 793.6 KB
.pad/809088 790.1 KB
.pad/804898 786.0 KB
.pad/801861 783.1 KB
.pad/799039 780.3 KB
pd-production-070122/125742_S2_M1_hospira-diluent-label.pdf 776.3 KB
.pad/793893 775.3 KB
.pad/790028 771.5 KB
.pad/778558 760.3 KB
.pad/778153 759.9 KB
.pad/771179 753.1 KB
.pad/767836 749.8 KB
.pad/759015 741.2 KB
.pad/758343 740.6 KB
pd-production-030122/125742_S1_M5_c4591001-T-S-suppl-arg.pdf 738.1 KB
.pad/745371 727.9 KB
.pad/741690 724.3 KB
.pad/735942 718.7 KB
pd-production-030122/125742_S1_M1_trans-of-oblig.pdf 717.1 KB
pd-production-030122/125742_S1_M1_356h.pdf 714.5 KB
.pad/727002 710.0 KB
.pad/721024 704.1 KB
pd-production-030122/125742_S1_M5_c4591001-T-S-roadmap.pdf 702.8 KB
.pad/718596 701.8 KB
pd-production-070122/125742_S2_M1_loa-dmf-011793-vials.pdf 701.1 KB
.pad/717662 700.8 KB
pd-production-030122/125742_S1_M1_financial-cert-bias.pdf 695.8 KB
pd-production-050222/FDA-CBER-2021-5683-0058316 to -0058458_125742_S1_M5_c4591001-A-Supp-define.xml 692.0 KB
pd-production-070122/125742_S2_M1_com195lpus-carton-puurs.pdf 691.1 KB
.pad/697841 681.5 KB
pd-production-040122/125742_S1_M5_5351_c4591001-fa-interim-invest-signature.pdf 677.1 KB
.pad/692090 675.9 KB
.pad/688988 672.8 KB
pd-production-070122/125742_S2_M1_com25ctpus-carton-puurs.pdf 671.9 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-any-malignancy.pdf 670.2 KB
pd-production-030122/125742_S1_M2_22_introduction.pdf 670.2 KB
.pad/683323 667.3 KB
pd-production-030122/125742_S1_M5_c4591001-T-S-summary-differences-csr-vs-update.pdf 666.8 KB
.pad/682006 666.0 KB
pd-production-030122/125742_S1_M1_ipsp-agreed-letter.pdf 657.8 KB
pd-production-030122/125742_S1_M1_debarment.pdf 656.4 KB
pd-production-030122/125742_S1_M1_fast-track-designation.pdf 649.4 KB
pd-production-070122/125742_S2_M1_comvlabp-vial-puurs.pdf 648.3 KB
.pad/659504 644.0 KB
.pad/659438 644.0 KB
.pad/659116 643.7 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-lymphoma.pdf 640.1 KB
.pad/653899 638.6 KB
pd-production-030122/125742_S1_M5_c4591001-A-comorbidity-categories.pdf 636.9 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.pdf 635.6 KB
pd-production-050222/125742_S1_M5_5351_bnt162-01-interim3-invest-signature.pdf 634.4 KB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.pdf 634.3 KB
.pad/647120 632.0 KB
pd-production-070122/125742_S2_M1_com25ctkz-carton-kzoo.pdf 631.9 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-cerebrovascular.pdf 631.6 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-periph-vasc.pdf 631.6 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-leukemia.pdf 631.4 KB
pd-production-070122/125742_S2_M1_loa-dmf-012683-vials.pdf 630.9 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-pulmonary.pdf 629.6 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-rheumatic.pdf 629.4 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-aids-hiv.pdf 629.1 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-renal.pdf 628.9 KB
.pad/643776 628.7 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mild-liver.pdf 628.4 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-chf.pdf 628.2 KB
pd-production-030122/125742_S1_M1_userfee.pdf 627.8 KB
pd-production-030122/125742_S1_M5_c4591001-A-bmi-12-15-scale.pdf 627.0 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.pdf 626.8 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-dementia.pdf 625.8 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.pdf 625.7 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.pdf 625.7 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-hemiplegia.pdf 625.6 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.pdf 624.8 KB
pd-production-030122/125742_S1_M5_c4591001-A-report-cci-mi.pdf 624.2 KB
.pad/636912 622.0 KB
.pad/635099 620.2 KB
pd-production-030122/125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.pdf 620.2 KB
.pad/633915 619.1 KB
.pad/632736 617.9 KB
.pad/632511 617.7 KB
pd-production-070122/125742_S2_M1_loa-dmf-011820-vials.pdf 616.2 KB
pd-production-030122/125742_S1_M1_exclusivity-claim.pdf 616.1 KB
.pad/629773 615.0 KB
.pad/625173 610.5 KB
pd-production-070122/125742_S2_M1_fk-diluent-carton.pdf 607.1 KB
pd-production-030122/125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.pdf 606.9 KB
pd-production-030122/125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.pdf 602.2 KB
pd-production-070122/125742_S2_M1_fk-diluent-stamp.pdf 598.2 KB
.pad/609976 595.7 KB
.pad/603729 589.6 KB
.pad/601728 587.6 KB
.pad/600698 586.6 KB
.pad/600163 586.1 KB
.pad/594476 580.5 KB
.pad/594323 580.4 KB
.pad/593072 579.2 KB
.pad/592102 578.2 KB
.pad/590670 576.8 KB
.pad/584327 570.6 KB
.pad/582248 568.6 KB
pd-production-070122/FDA-CBER-2021-5683-0286072 to -0286266_125742_S1_M5_c4591001-S-Supp-D-relrec.xpt 568.2 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002376_relrec.xpt 566.6 KB
.pad/577797 564.3 KB
.pad/575971 562.5 KB
.pad/562980 549.8 KB
.pad/562720 549.5 KB
.pad/557732 544.7 KB
.pad/555658 542.6 KB
.pad/555434 542.4 KB
.pad/552114 539.2 KB
.pad/550361 537.5 KB
.pad/547979 535.1 KB
.pad/525081 512.8 KB
.pad/518792 506.6 KB
.pad/515047 503.0 KB
.pad/512521 500.5 KB
.pad/508004 496.1 KB
.pad/501069 489.3 KB
.pad/495274 483.7 KB
pd-production-070122/FDA-CBER-2021-5683-0282329 to -0282365_125742_S1_M5_c4591001-S-D-ie.xpt 479.6 KB
.pad/489504 478.0 KB
.pad/484750 473.4 KB
.pad/478144 466.9 KB
.pad/470569 459.5 KB
.pad/463782 452.9 KB
.pad/462617 451.8 KB
.pad/446062 435.6 KB
.pad/439744 429.4 KB
.pad/432507 422.4 KB
.pad/429379 419.3 KB
.pad/408351 398.8 KB
.pad/407232 397.7 KB
.pad/398152 388.8 KB
.pad/391315 382.1 KB
.pad/388238 379.1 KB
.pad/387110 378.0 KB
.pad/384753 375.7 KB
.pad/357464 349.1 KB
.pad/327366 319.7 KB
.pad/325554 317.9 KB
.pad/313184 305.8 KB
.pad/312541 305.2 KB
.pad/308694 301.5 KB
pd-production-050222/FDA-CBER-2021-5683-0058615 to -0058652_125742_S1_M5_c4591001-S-Supp-define.xml 299.8 KB
.pad/303249 296.1 KB
.pad/299998 293.0 KB
.pad/297052 290.1 KB
.pad/293877 287.0 KB
.pad/293428 286.6 KB
.pad/282076 275.5 KB
.pad/274455 268.0 KB
.pad/273415 267.0 KB
.pad/264301 258.1 KB
.pad/263583 257.4 KB
.pad/249009 243.2 KB
.pad/248172 242.4 KB
.pad/245954 240.2 KB
.pad/245429 239.7 KB
.pad/234376 228.9 KB
pd-production-121321/signed-F21-5683-CBER-Dec-13-2021-Response-Letter.pdf 206.6 KB
.pad/204688 199.9 KB
pd-production-030122/FDA-CBER-2021-5683-0022867 to -0023006_125742_S1_M5_c4591001-A-P-adsl-sas.txt 197.2 KB
.pad/201198 196.5 KB
pd-production-030122/FDA-CBER-2021-5683-0022136 to -0022325_125742_S1_M5_c4591001-A-P-adce-s020-se-p3-saf-sas.txt 192.9 KB
.pad/196859 192.2 KB
.pad/193244 188.7 KB
pd-production-030122/FDA-CBER-2021-5683-0023455 to -0023486_125742_S1_M5_c4591001-A-define-2-0-0.xsl 183.3 KB
pd-production-050222/FDA-CBER-2021-5683-0058459 to -0058478_125742_S1_M5_c4591001-A-Supp-define-2-0-0.xsl 183.3 KB
pd-production-050222/FDA-CBER-2021-5683-0058595 to -0058614_125742_S1_M5_c4591001-S-define-2-0-0.xsl 183.3 KB
pd-production-050222/FDA-CBER-2021-5683-0058653 to -0058675_125742_S1_M5_c4591001-S-Supp-define-2-0-0.xsl 183.3 KB
pd-production-050222/FDA-CBER-2021-5683-0058795 to -0058828_125742_S1_M5_bnt162-01-A-define-2-0-0.xsl 183.3 KB
pd-production-050222/FDA-CBER-2021-5683-0058955 to -0058999_125742_S1_M5_bnt162-01-S-define-2-0-0.xsl 183.3 KB
.pad/163943 160.1 KB
pd-production-030122/FDA-CBER-2021-5683-0022365 to -0022560_125742_S1_M5_c4591001-A-P-adds-s002-all-p3-rand-sas.txt 155.8 KB
.pad/128947 125.9 KB
.pad/124421 121.5 KB
.pad/105781 103.3 KB
.pad/96323 94.1 KB
pd-production-030122/FDA-CBER-2021-5683-0023711 to -0023875_125742_S1_M5_c4591001-A-newlist-c4591001-6k-participants-enrolled-v3-17sep2020.xlsx 84.1 KB
pd-production-030122/FDA-CBER-2021-5683-0021981 to -0022027_125742_S1_M5_c4591001-A-P-adc19ef-sas.txt 81.1 KB
pd-production-070122/FDA-CBER-2021-5683-0285644 to -0285651_125742_S1_M5_c4591001-S-D-mo.xpt 75.8 KB
pd-production-030122/FDA-CBER-2021-5683-0022793 to -0022866_125742_S1_M5_c4591001-A-P-adsl-s005-demo-all-p3-saf-sas.txt 75.4 KB
pd-production-030122/FDA-CBER-2021-5683-0022692 to -0022765_125742_S1_M5_c4591001-A-P-adsl-demo-7d-wwo-eval-eff-sas.txt 74.7 KB
pd-production-030122/FDA-CBER-2021-5683-0022618 to -0022691_125742_S1_M5_c4591001-A-P-adsl-demo-7d-eval-eff-sas.txt 74.6 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002377_supppr.xpt 71.8 KB
pd-production-030122/FDA-CBER-2021-5683-0022063 to -0022135_125742_S1_M5_c4591001-A-P-adce-s010-lr-p3-saf-sas.txt 71.6 KB
.pad/66254 64.7 KB
.pad/62752 61.3 KB
.pad/56828 55.5 KB
pd-production-030122/FDA-CBER-2021-5683-0022568 to -0022600_125742_S1_M5_c4591001-A-P-adfacevd-sas.txt 48.9 KB
.pad/48583 47.4 KB
pd-production-030122/FDA-CBER-2021-5683-0023032 to -0023065_125742_S1_M5_c4591001-A-P-adva-sas.txt 44.8 KB
pd-production-030122/FDA-CBER-2021-5683-0023007 to -0023031_125742_S1_M5_c4591001-A-P-adsympt-sas.txt 43.2 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002380_ti.xpt 37.0 KB
pd-production-030122/FDA-CBER-2021-5683-0021944 to -0021963_125742_S1_M5_c4591001-A-P-adae-sas.txt 35.5 KB
pd-production-030122/FDA-CBER-2021-5683-0023895 to -0023915_125742_S1_M5_c4591001-A-report-cci-any-malignancy.xlsx 34.8 KB
pd-production-030122/FDA-CBER-2021-5683-0022346 to -0022364_125742_S1_M5_c4591001-A-P-adcm-sas.txt 32.2 KB
pd-production-030122/FDA-CBER-2021-5683-0022766 to -0022792_125742_S1_M5_c4591001-A-P-adsl-fu-d2-p3-saf-sas.txt 29.2 KB
pd-production-030122/FDA-CBER-2021-5683-0023500 to -0023507_125742_S1_M5_c4591001-A-c4591001-phase-1-subjects-from-dmw.xlsx 28.7 KB
pd-production-030122/FDA-CBER-2021-5683-0022326 to -0022345_125742_S1_M5_c4591001-A-P-adcevd-sas.txt 27.1 KB
.pad/27462 26.8 KB
pd-production-030122/FDA-CBER-2021-5683-0022601 to -0022617_125742_S1_M5_c4591001-A-P-admh-sas.txt 24.0 KB
pd-production-030122/FDA-CBER-2021-5683-0023983 to -0023984_125742_S1_M5_c4591001-A-report-cci-rheumatic.xlsx 23.9 KB
pd-production-030122/FDA-CBER-2021-5683-0023878_125742_S1_M5_c4591001-A-report-cci-aids-hiv.xlsx 22.7 KB
pd-production-030122/FDA-CBER-2021-5683-0023550 to -0023569_125742_S1_M5_c4591001-A-first-c4591001-360-participants-enrolled-v1-13aug20-update.xlsx 22.3 KB
pd-production-030122/FDA-CBER-2021-5683-0023987_125742_S1_M5_c4591001-A-201114-hiv-preferred-terms.xlsx 21.3 KB
pd-production-030122/FDA-CBER-2021-5683-0022028 to -0022040_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-sg-eval-sas.txt 19.6 KB
pd-production-030122/FDA-CBER-2021-5683-0022041 to -0022053_125742_S1_M5_c4591001-A-P-adc19ef-ve-cov-7pd2-wo-sg-eval-sas.txt 19.5 KB
pd-production-030122/FDA-CBER-2021-5683-0023540_125742_S1_M5_c4591001-A-comorbidity-categories.xlsx 18.9 KB
pd-production-030122/FDA-CBER-2021-5683-0023523 to -0023538_125742_S1_M5_c4591001-A-c4591001-subject-list-for-12-25-immuno-analysis-27jan2021.xlsx 18.5 KB
pd-production-030122/FDA-CBER-2021-5683-0021964 to -0021980_125742_S1_M5_c4591001-A-P-adae-vax-tier2-p3-saf-sas.txt 17.9 KB
pd-production-030122/FDA-CBER-2021-5683-0023944 to -0023950_125742_S1_M5_c4591001-A-report-cci-lymphoma.xlsx 17.0 KB
.pad/16016 15.6 KB
pd-production-111721/BATES-93_tv.xpt 15.5 KB
pd-production-030122/FDA-CBER-2021-5683-0021930 to -0021943_125742_S1_M5_c4591001-A-P-adae-s092-cr-cut-p3x-saf-sas.txt 15.1 KB
.pad/15248 14.9 KB
pd-production-030122/FDA-CBER-2021-5683-0021916 to -0021929_125742_S1_M5_c4591001-A-P-adae-s092-all-unb-p3-saf-sas.txt 14.7 KB
pd-production-030122/FDA-CBER-2021-5683-0021902 to -0021915_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf2-sas.txt 14.7 KB
pd-production-030122/FDA-CBER-2021-5683-0023955 to -0023958_125742_S1_M5_c4591001-A-report-cci-metastatic-tumour.xlsx 14.3 KB
pd-production-030122/FDA-CBER-2021-5683-0021888 to -0021901_125742_S1_M5_c4591001-A-P-adae-s091-all-pd2-p3-saf1-sas.txt 13.9 KB
pd-production-030122/FDA-CBER-2021-5683-0023490 to -0023491_125742_S1_M5_c4591001-A-bmi-12-15-scale.xlsx 13.0 KB
pd-production-030122/FDA-CBER-2021-5683-0023919 to -0023921_125742_S1_M5_c4591001-A-report-cci-cerebrovascular.xlsx 12.4 KB
pd-production-030122/FDA-CBER-2021-5683-0022054 to -0022062_125742_S1_M5_c4591001-A-P-adc19ef-ve-sev-cov-pd1-aai-sas.txt 12.3 KB
pd-production-030122/FDA-CBER-2021-5683-0023971 to -0023972_125742_S1_M5_c4591001-A-report-cci-periph-vasc.xlsx 11.7 KB
pd-production-030122/FDA-CBER-2021-5683-0023936 to -0023937_125742_S1_M5_c4591001-A-report-cci-leukemia.xlsx 11.7 KB
pd-production-030122/FDA-CBER-2021-5683-0023975 to -0023976_125742_S1_M5_c4591001-A-report-cci-pulmonary.xlsx 11.6 KB
.pad/11541 11.3 KB
pd-production-030122/FDA-CBER-2021-5683-0023979 to -0023980_125742_S1_M5_c4591001-A-report-cci-renal.xlsx 11.1 KB
pd-production-030122/FDA-CBER-2021-5683-0022561 to -0022567_125742_S1_M5_c4591001-A-P-adds-sas.txt 11.0 KB
pd-production-030122/FDA-CBER-2021-5683-0023963_125742_S1_M5_c4591001-A-report-cci-mild-liver.xlsx 10.3 KB
pd-production-030122/FDA-CBER-2021-5683-0023924_125742_S1_M5_c4591001-A-report-cci-chf.xlsx 10.3 KB
pd-production-030122/FDA-CBER-2021-5683-0023930_125742_S1_M5_c4591001-A-report-cci-diabetes-without-comp.xlsx 9.8 KB
pd-production-030122/FDA-CBER-2021-5683-0023932_125742_S1_M5_c4591001-A-report-cci-hemiplegia.xlsx 9.6 KB
pd-production-030122/FDA-CBER-2021-5683-0023926_125742_S1_M5_c4591001-A-report-cci-dementia.xlsx 9.4 KB
pd-production-030122/FDA-CBER-2021-5683-0023928_125742_S1_M5_c4591001-A-report-cci-diabetes-with-comp.xlsx 9.2 KB
pd-production-030122/FDA-CBER-2021-5683-0023965_125742_S1_M5_c4591001-A-report-cci-mod-sev-liver.xlsx 9.2 KB
pd-production-030122/FDA-CBER-2021-5683-0023967_125742_S1_M5_c4591001-A-report-cci-peptic-ulcer.xlsx 9.2 KB
pd-production-111721/BATES-92_adc19ef-ve-cov-7pd2-wo-eval-sas.txt 9.1 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002374_adc19ef-ve-sev-cov-7pd2-wo-eval-sas.txt 9.1 KB
pd-production-030122/FDA-CBER-2021-5683-0023960_125742_S1_M5_c4591001-A-report-cci-mi.xlsx 8.9 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002373_adc19ef-ve-sev-cov-7pd2-eval-sas.txt 8.5 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002372_adc19ef-ve-cov-7pd2-eval-sas.txt 8.5 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002378_ta.xpt 8.4 KB
.pad/6144 6.0 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002375_addv-sas.txt 4.5 KB
pd-production-121321/BATES-FDA-CBER-2021-5683-0002379_te.xpt 3.3 KB

The Pfizer Documents - July 2022 Update

File List

Download Torrent

Related Resources

Copyright Infringement